Armata Pharmaceuticals (ARMP) Shares Outstanding (Diluted Average) (2013 - 2026)

Armata Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 14 years of filings, most recently posting $36.5 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $36.5 million, down 38.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.5 million (down 38.58% YoY), and the FY2023 annual result was $36.1 million, up 5.19% from the prior year.
• Shares Outstanding (Diluted Average) came in at $36.5 million for Q1 2026 at Armata Pharmaceuticals, up from $36.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $59.5 million in Q1 2025 to a low of $29.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $36.1 million (2024), against an average of $39.7 million.
• Across the five-year window, Shares Outstanding (Diluted Average) surged 73.89% in 2023 and plunged 38.58% in 2026, its largest moves.
• Armata Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $34.3 million in 2022, then grew by 5.19% to $36.1 million in 2023, then gained by 0.29% to $36.2 million in 2024, then gained by 0.06% to $36.2 million in 2025, then rose by 0.91% to $36.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $36.5 million (Q1 2026), $36.2 million (Q3 2025), and $36.2 million (Q2 2025), per Business Quant data.